丙种球蛋白辅助治疗小儿支原体肺炎的临床效果观察

目的：观察丙种球蛋白辅助治疗小儿支原体肺炎的临床效果。方法：选择我院2009年10月～2010年12月收治的106例4,JL支原体肺炎，随机分为观察组（53例）和对照组（53例），对照组采用常规治疗，观察组加用丙种球蛋白辅助治疗，比较分析两组的临床效果。结果：观察组的总有效率为98．1％，明显高于对照组84．9％，两组比较有显著性差异（x2=4．3711，P〈0．05）。两组不良反应发生率分别为7．5％、3．8％，两组比较无显著性差异（x2=0．5082，P〉0．05）。结论：丙种球蛋白辅助治疗小儿支原体肺炎的临床效果更佳，且安全可靠，可以作为临床的首选治疗方法之一。

Observation of clinical effect of Gamma Globulin in adjuvant therapy of children with pneumonia

Objective： To observe the clinical_ observation of Gamma Globulin in adjuvant therapy of children with MP pneumonia. Methods： From October 2009 to December 2010 in our hospital, 106 cases of MP pneumonia were randomly divided into observation group （n=53）and control group （n=53）. The control group with conventional treatment, and the observation group were treated with Gamma Globulin adjuvant treatment, then compared the clinical results of two groups. Results：The total effective rate of observation group was 98.1% and the control group was 84.9%, there were significant differences in the two groups（ X 2=4.3711,P 〈 0.05）. The adverse reactions of two groups were 7.5% and 3.8%, there was no significant difference of two groups（ X 2=0.5082,P 〉 0.05）. Conclusion：Gamma Globulin in adjuvant therapy of children with MP pneumonia has better clinical effect and secure, can be used as the first choice of clinical treat- ment methods.